
Articles
-
Jan 17, 2025 |
cei.org | Joel Zinberg
Competitive Enterprise Institute (CEI) senior fellow Dr. Joel Zinberg was named as Special Assistant to the President for Economic Policy (Healthcare) at the White House today by the Transition Team. Dr. Zinberg will advise the President on healthcare issues from the National Economic Council (NEC).
-
Dec 19, 2024 |
city-journal.org | Joel Zinberg |Liam Sigaud
Next year will be an important one for American health. Donald Trump’s incoming administration has pledged a new focus on chronic diseases in hopes of better understanding and preventing what makes us sick. Next year, we’ll also see the expiration of the expanded government subsidies that boosted Affordable Care Act insurance-exchange enrollments. Democrats are pushing to extend these subsidies, but Trump and the GOP should resist the pressure.
-
Dec 2, 2024 |
wsj.com | Joel Zinberg
The Biden administration announced one more bit of executive overreach on its way out the door. On Nov. 26, the Centers for Medicare and Medicaid Services proposed a rule that would require its health-insurance programs to cover weight-loss drugs for patients with obesity. These drugs, which include Wegovy and Zepbound, are extremely effective and expensive. CMS estimates the proposal would cost the federal government about $40 billion over 10 years.
-
Dec 2, 2024 |
cei.org | Joel Zinberg
The Biden administration announced one more bit of executive overreach on its way out the door. On Nov. 26, the Centers for Medicare and Medicaid Services proposed a rule that would require its health-insurance programs to cover weight-loss drugs for patients with obesity. These drugs, which include Wegovy and Zepbound, are extremely effective and expensive. CMS estimates the proposal would cost the federal government about $40 billion over 10 years.
-
Nov 25, 2024 |
cei.org | Joel Zinberg
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more accessible to Americans. A new study I authored suggests it should proceed with caution.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →